Is Sermorelin Legal in Colorado?

Print or save as PDF

See the public record for Sermorelin

  • FDA approval / None. Geref's approvals were withdrawn effective June 18, 2009 [1]
  • Sold today / Compounded sermorelin, which FDA has not approved [4]
  • Safety-risk page / Sermorelin is not listed (content dated 04/22/2026) [5]
  • Outsourcing-facility list / Sermorelin acetate is category 1, under evaluation (updated March 21, 2025) [2]
  • State-licensed pharmacy list / Sermorelin appears in no category (updated May 14, 2026) [3]
  • Sport / Prohibited at all times by WADA [6][7]

What is sermorelin's federal status?

Sermorelin acetate was approved twice, both times as Geref (EMD Serono). NDA 019863, a 0.05 mg/ampule product approved December 28, 1990, was a diagnostic test of the pituitary's ability to secrete growth hormone. NDA 020443, 0.5 mg and 1 mg vials approved September 26, 1997, was for treating idiopathic growth hormone deficiency in children with growth failure [1]. Geref was never approved for adults, anti-aging, weight loss or athletic performance [1].

The manufacturer discontinued both products in 2008 and asked FDA to withdraw the applications; FDA withdrew both approvals effective June 18, 2009. In March 2013 FDA determined Geref was not withdrawn from sale for reasons of safety or effectiveness [1][8].

That leaves compounding. Sermorelin products sold in the US today are compounded, not FDA-approved, and FDA does not review a compounded drug's safety, effectiveness or quality before it is marketed [4].

Where sermorelin sits on FDA's compounding lists

  • It is not on FDA's page of bulk substances that may present significant safety risks when compounded (content dated 04/22/2026) [5].
  • On the list of nominated bulk substances for outsourcing facilities, sermorelin acetate is category 1, under evaluation, and carries the list's symbol for substances that are components of FDA-approved drugs (updated March 21, 2025) [2].
  • It appears in no category on the list for state-licensed pharmacies and physicians (updated May 14, 2026) [3], and it is not one of the six peptides in HHS's October 2026 draft enforcement-discretion policy [9].

What about Colorado specifically?

The material above is federal: approval history, FDA compounding lists and an HHS draft policy. None of it states a Colorado rule, so it cannot confirm whether a particular prescription or compounded product meets Colorado requirements.

Questions worth asking

Choose the questions you want to keep

What sermorelin is, and what it does

Sermorelin is a 29-amino-acid analogue of human growth hormone-releasing hormone, the shortest synthetic peptide with the full biological activity of GHRH. It is not growth hormone [10]. It acts on the pituitary's GHRH receptor to prompt release of the body's own growth hormone; after an intravenous dose in healthy men it was eliminated quickly, while growth hormone stayed raised for about 3 hours [10][11].

Sermorelin is banned in sport

WADA's 2026 Prohibited List names sermorelin in S2.2.4, growth hormone releasing factors, prohibited at all times, in and out of competition, as a non-Specified Substance; the 2027 List, in force January 1, 2027, names it too [6][7].

Is sermorelin FDA-approved?
No. Geref was approved for a pituitary diagnostic test and for treating idiopathic growth hormone deficiency in children with growth failure, and both applications were withdrawn effective June 18, 2009 [1]. Compounded sermorelin is not FDA-approved [4].
Is sermorelin legal in Colorado?
No sermorelin product is FDA-approved [1], and what is sold in the US today is compounded [4]. On FDA's lists, sermorelin acetate is category 1 (under evaluation) for outsourcing facilities and appears in no category for state-licensed pharmacies and physicians [2][3].
Why was Geref taken off the market?
The manufacturer discontinued it in 2008 and asked FDA to withdraw the applications. In March 2013 FDA determined that Geref was not withdrawn from sale for reasons of safety or effectiveness [1].
What dose of sermorelin is approved?
None, because no sermorelin product is currently FDA-approved [1]. The doses used in studies were 30 micrograms per kg subcutaneously at bedtime in children and 0.5 mg or 1 mg subcutaneously twice daily for 14 days in older men; those are study doses, not recommendations [12][13].
Is sermorelin allowed in sport?
No. WADA's 2026 Prohibited List names sermorelin in S2.2.4 and prohibits it at all times, in and out of competition [6]; the 2027 List names it as well [7].
Show all 13 referencesHide references
  1. Federal Register :: Request Access.
  2. U.S. Food and Drug Administration.
  3. U.S. Food and Drug Administration.
  4. Official web page.
  5. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  6. World Anti-Doping Agency.
  7. World Anti-Doping Agency.
  8. U.S. Food and Drug Administration.
  9. Official web page.
  10. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  11. Wilton P, Chardet Y, Danielson K, Widlund L, Gunnarsson R. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10-5.
  12. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  13. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
Sermorelin Colorado: evidence summary chart
Image: HealthRX.com. Full sermorelin Colorado guide and sources at healthrx.com/peptide-legal-sermorelin.